Nephrotoxicity and its prevention by taurine in tamoxifen induced oxidative stress in mice

Human and Experimental Toxicology

Volumn 26, Issue 6, 2007, Pages 509-518

  Tabassum, Heena ^a,c   Parvez, Suhel ^b,d   Rehman, Hasibur ^a   Banerjee, Basu Dev ^c   Siemen, Detlef ^b   Raisuddin, Sheikh ^a  

^a HAMDARD UNIVERSITY   (India)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c UCMS AND GTB HOSPITAL   (India)

^d UNIVERSITY OF HAWAII   (United States)

Author keywords

Antioxidant enzymes; Nephrotoxicity; Oxidative stress; Tamoxifen; Taurine

Indexed keywords

ANTIOXIDANT; CARBONYL DERIVATIVE; CYTOCHROME P450; DRUG METABOLIZING ENZYME; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; TAMOXIFEN; TAURINE;

ARTICLE; BREAST CANCER; ENZYME ACTIVITY; HEXOSE MONOPHOSPHATE SHUNT; LIPID PEROXIDATION; MALE; MOUSE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RENAL PROTECTION; TISSUE INJURY;

ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; CATALASE; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME ACTIVATION; ESTROGEN ANTAGONISTS; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; INJECTIONS, INTRAPERITONEAL; KIDNEY; KIDNEY DISEASES; LIPID PEROXIDATION; MALE; MICE; OXIDATIVE STRESS; PROTEIN CARBONYLATION; SULFHYDRYL COMPOUNDS; SUPEROXIDE DISMUTASE; TAMOXIFEN; TAURINE;

ANIMALIA; MUS;

EID: 34547683498     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/0960327107072392     Document Type: Article

References (50)

1. Cardoso CM, Custodio JB, Almeida LM, Moreno AJ. Mechanisms of the delterious effects of tamoxifen on mitochondrial respiration rate and phosphorylation efficiency. Toxicol Appl Pharmacol 2001; 176: 145-52.
2. Noureddin BN, Seoud M, Bashshur Z, Salem Z, Shamseddin A, Khalil A. Ocular toxicity in low-dose tamoxifen: a prospective study. Eye 1999; 13: 729-33.
3. Li AP, Bode C, Sakai Y. A novel in vitro system, the integrated discrete multiple organ cell culture (IdMOC) system, for the evaluation of human drug toxicity: comparative cytotoxicity of tamoxifen towards normal human cells from five major organs and MCF-7 adenocarcinoma breast cancer cells. Chem Biol Interact 2004; 150: 129-36.
4. Dragan Y, Fahey S, Nuwaysir E, Sattler C, Babcock K, Vaughan J, McCague R, Jordan VC, Pitot HC. The effect of tamoxifen and two of its non-isomerizable fixedring analogs on multistage rat hepatocarcinogenesis. Carcinogenesis 1996; 17: 585-94.
5. Parlakpinar H, Tasdemir S, Polat A, Bay-Karabulut A, Vardi N, Ucar M, Acet A. Protective role of caffeic acid phenethyl ester (cape) on gentamicin-induced acute renal toxicity in rats. Toxicology 2005; 207: 169-77.
6. Ozen S, Akyol O, Iraz M, Sogut S, Ozugurlu F, Ozyurt H. Odaci E, Yildirim Z. Role of caffeic acid phenethyl ester, an active component of propolis, against cisplatin-induced nephrotoxicity in rats. J Appl Toxicol 2004; 24: 27-35.
7. Saad SY, Al-Rikabi AC. Protection effects of taurine supplementation against cisplatin-induced nephrotoxicity in rats. Chemotherapy 2002; 48: 42-48.
8. Heller-Stilb B, Van Roeyen C, Rascher K, Hartwig HG, Huth A, Seeliger MW, Warskulat U, Haussinger D. Disruption of the taurine transporter gene (taut) leads to retinal degeneration in mice. FASEB J 2002; 16: 231-33.
9. Han X, Budreau AM, Chesney RW. The taurine transporter gene and its role in renal development. Amino Acids 2000; 19: 499-507.
10. Waterfield CJ, Mesquita M, Parnham P, Timbrell JA. Cytoprotective effects of taurine in isolated rat hepatocytes. Toxicol In Vitro 1994; 8: 573-75.
11. Timbrell JA, Seabra V, Waterfield CJ. The in vivo and in vitro protective properties of taurine. Gen Pharmacol 1995; 26: 453-62.
12. Hamaguchi T, Azuma J, Awata N, Ohta H, Takihara K, Harada H, Kishimoto S, Sperelakis N. Reduction of doxorubicin-induced cardiotoxicity in mice by taurine. Res Commun Chem Pathol Pharmacol 1988; 59: 21-30.
13. Han X, Chesney RW. Regulation of TauT bv cisplatin in LLC-PK1 renal cells. Pediatr Nephrol 2005; 20: 1067-72.
14. Smith KE, Borden LA, Wang CH, Hartig PR, Branchek TA, Weinshank RL. Cloning and expression of a high affinity taurine transporter from rat brain. Mol Pharmacol 1992; 42: 563-69.
15. Huxtable RJ. Physiological actions of taurine. Physiol Rev 1992; 72: 101-63.
16. Karki A, Mantyla E, Hirsimaki Y, Karlsson S, Toikkanen S, Hirsimaki P. Comparison of the effects of tamoxifen and toremifene on rat hepatocarcinogenesis. Arch Toxicol 2000; 74: 249-56.
17. El-Beshbishy HA. The effect of dimethyl dimethoxy biphenyl dicarboxylate (DDB) against tamoxifen-induced liver injury in rats: DDB use is curative or protective. J Biochem Mol Biol 2005; 38: 300-306.
18. Dogru-Abbasoglu S, Kanbagli O, Balkan J, Cevikbas U, Aykac-Toker G, Uysal M. The protective effect of taurine against thioacetamide hepatotoxicity of rats. Hum Exp Toxicol 2001; 20: 23-27.
19. Hayes J, Tipton KF, Bianchi L, Corte LD. Complexities in the neurotoxic actions of 6-hydroxydopamine in relation to the cytoprotective properties of taurine. Brain Res Bull 2001; 55: 239-45.
20. Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978; 86: 271-78.
21. Floor E, Wetzel MG. Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay. J Neurochem 1998; 70: 268-75.
22. Omura T, Sato R. The carbon monoxide-binding pigment of kidney microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 1964; 239: 2370-78.
23. Haque R, Bin-Hafeez B, Parvez S, Pandey S, Sayeed I, Ali M, Raisuddin S. Aqueous extract of walnut (Juglans regia L.) protects mice against cyclophosphamide induced biochemical toxicity. Hum Exp Toxicol 2003; 22: 473-80.
24. Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 1968; 25: 192-205.
25. Majhi S, Jena BS, Patnaik BK. Effect of age on lipid peroxides, lipofuscin and ascorbic acid contents of the lungs of male garden lizard. Comp Biochem Physiol 2000; 126: 293-98.
26. Mohandas J, Marshall JJ, Duggin GG, Horvath JS, Tiller DJ. Low activities of glutathione-related enzymes as factors in the genesis of urinary bladder cancer. Cancer Pes 1984; 44: 5086-91.
27. Zaheer N, Tewari KK, Krishnan PS. Mitochondrial forms of glucose 6-phosphate dehydrogenase and 6-phosphogluconic acid dehydrogenase in rat liver. Arch Biochem Biophys 1967; 120: 22-34.
28. Claiborne A. Catalase activity. In Greenwald RA ed. CBC handbook of methods in oxygen radical research. CRC Press, 1985: 283-84.
29. Beauchamp C, Fridovich I. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem 1971; 44: 276-87.
30. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
31. Oktem F, Ozguner F, Sulak O, Olgar S, Akturk O, Yilmaz HR, Altuntas I. Lithium-induced renal toxicity in rats: protection by a novel antioxidant caffeic acid phenethyl ester. Mol Cell Biochem 2005; 277: 109-15.
32. Salminen A, Vihko V. Lipid peroxidation in exercise myopathy. Exp Mol Pathol 1983; 38: 380-88.
33. Nakashima T, Taniko T, Kuriyama K. Therapeutic effect of taurine administration on carbon tetrachloride-induced hepatic injury. Jpn J Pharmacol 1982; 32: 583-89.
34. Nittynen L, Nurminen ML. Korpela R, Vapaatalo H. Role of arginine, taurine and homocysteine in cardiovascular diseases. Ann Med 1999; 31: 318-26.
35. Berlett BS, Stadtman ER. Protein oxidation in ageing, disease and oxidative stress. J Biol Chem 1997; 272: 20313-16.
36. Pathak DN, Bodell WJ. DNA adduct formation by tamoxifen with rat and human liver microsomal activating systems. Carcinogenesis 1994; 15: 529-32.
37. Yamamoto K, Masubuchi Y, Narimatsu S, Kobayashi S, Horie T. Rat liver microsomal lipid peroxidation produced during the oxidative metabolism of ethacrynic acid. Pharmacol Toxicol 2001; 88: 176-80.
38. Lee DW, Yu BP. Microsomal cytochrome P-450 degradation by in vitro lipid peroxidation. J Nutr Health Aging 1998; 2: 162-66.
39. Brittebo EB, Darnerud PO, Eriksson C, Brandt I. Nephrotoxicity and covalent binding of 1,1-dichloroethylene in buthionine sulphoximine-treated mice. Arch Toxicol 1993; 67: 605-12.
40. Singh RP, Banerjee S, Kumar PV, Raveesha KA, Rao AR. Tinospora cordifolia induces enzymes of carcinogen/drug metabolism and antioxidant system, and inhibits lipid peroxidation in mice. Phytomedicine 2006; 13: 74-84.
41. Guemouri L, Artur Y, Herbeth B, Jeandel C, Cuny G, Siest G. Biological variability of superoxide dismutase, glutathione peroxidase, and catalase in blood. Clin Chem 1991; 37: 1932-37.
42. Beckett GJ, Hayes JD. Glutathione S-transferases: biomedical applications. Adv Clin Chem 1993; 30: 281-380.
43. Chaudiere J, Ferrari-Iliou R. Intracellular antioxidants: from chemical to biochemical mechanisms. Food Chem Toxicol 1999; 37: 949-62.
44. Ho HY, Cheng ML, Chiu DT. G6PD-an old bottle with new wine. Chang Gung Med J 2005; 28: 606-12.
45. Landi S. Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat Res 2000; 463: 247-83.
46. Fadillioglu E, Erdogan H, Sogut S, Kuku I. Protective effects of erdosteine against doxorubicin-induced cardiomyopathy in rats. J Appl Toxicol 2003; 23: 71-74.
47. Yilmaz HR, Uz E, Yucel N, Altuntas I, Ozcelik N. Protective effect of caffeic ccid phenethyl ester (CAPE) on lipid peroxidation and antioxidant enzymes in diabetic rat liver. J Biochem Mol Toxicol 2004; 18: 234-38.
48. Nicholls DG, Budd SL. Mitochondria and neuronal survival. Physiol Rev 2000; 80: 315-60.
49. Wu KK. Inducible cyclooxygenase and nitric oxide synthase. Adv Pharmacol 1995; 33: 179-207.
50. Schmedtje JF, Ji YS, Liu WL, DuBois RN, Runge MS. Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. J Biol Chem 1997; 272: 601-608.